Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20712801 | 0.77 | MAPK1 (0.35) | MEN1LMNAKMT2AMAPK1 | |
| SCHEMBL13004398 | 0.76 | — | — | |
| SCHEMBL21651050 | 0.76 | MEN1 (0.38) | MEN1LMNAKMT2AS1PR1S1PR3 | |
| SCHEMBL8365 | 0.74 | — | — | |
| SCHEMBL8531420 | 0.74 | MEN1 (0.60) | MEN1LMNAKMT2AS1PR1S1PR3 | |
| SCHEMBL45629 | 0.74 | — | — | |
| SCHEMBL6026252 | 0.73 | MAPK1 (0.33) | MEN1LMNAKMT2AMAPK1 | |
| Deanol SCHEMBL10476577 | 0.72 | MEN1 (0.50) | MEN1LMNAKMT2AS1PR1S1PR3 | |
| Bromide SCHEMBL1472016 | 0.72 | — | — | |
| Ammonia Solution, Strong SCHEMBL15322546 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7002010-B2 | Process for the preparation of morpholinones as light stabilizers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-02-21 | — | — | US | disclosed |
| US-20040024252-A1 | Process for the preparation of morpholinones as light stabilizers | CIBA SPECIALTY CHEMICALS CORP. | 2004-02-05 | — | — | US | disclosed |
| EP-1341775-A2 | PROCESS FOR THE PREPARATION OF MORPHOLINONES | Ciba SC Holding AG (CH) | 2003-09-10 | — | — | EP | disclosed |
| WO-2002048123-A2 | PROCESS FOR THE PREPARATION OF MORPHOLINONES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024252-A1 | Process for the preparation of morpholinones as light stabilizers | TMT1A, SEM1, MITF | MEN1 1807/4885LMNA 678/4885KMT2A 587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.